ID19589A - Komposisi - Google Patents

Komposisi

Info

Publication number
ID19589A
ID19589A IDP973137A ID973137A ID19589A ID 19589 A ID19589 A ID 19589A ID P973137 A IDP973137 A ID P973137A ID 973137 A ID973137 A ID 973137A ID 19589 A ID19589 A ID 19589A
Authority
ID
Indonesia
Prior art keywords
composition
Prior art date
Application number
IDP973137A
Other languages
English (en)
Inventor
Susan Marie Milosovich
William Muldoon
Joseph Sauer
James Albert Napper
Laurence Rousseau
Original Assignee
Smithkline Beecham Plc
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc, Smithkline Beecham Corp filed Critical Smithkline Beecham Plc
Publication of ID19589A publication Critical patent/ID19589A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
IDP973137A 1996-09-12 1997-09-10 Komposisi ID19589A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9619074.9A GB9619074D0 (en) 1996-09-12 1996-09-12 Composition

Publications (1)

Publication Number Publication Date
ID19589A true ID19589A (id) 1998-07-23

Family

ID=10799833

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP973137A ID19589A (id) 1996-09-12 1997-09-10 Komposisi

Country Status (22)

Country Link
EP (1) EP0929301A2 (id)
JP (1) JP2001500150A (id)
KR (1) KR20000036039A (id)
CN (2) CN1235544A (id)
AR (1) AR008176A1 (id)
AU (1) AU724086B2 (id)
BR (1) BR9711734A (id)
CA (1) CA2265661A1 (id)
CO (1) CO5031291A1 (id)
CZ (1) CZ83299A3 (id)
GB (1) GB9619074D0 (id)
HU (1) HUP9904401A3 (id)
ID (1) ID19589A (id)
IL (1) IL128781A0 (id)
MA (1) MA24359A1 (id)
NO (1) NO991194D0 (id)
NZ (1) NZ334268A (id)
PE (1) PE2499A1 (id)
PL (1) PL332074A1 (id)
TR (1) TR199900505T2 (id)
WO (1) WO1998010762A2 (id)
ZA (1) ZA978133B (id)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2775597B1 (fr) * 1998-03-04 2001-04-20 Gattefosse Ets Sa Pellet administrable par voie orale apte a ameliorer la biodisponibilite de la substance active, procede de fabrication
WO1999045924A1 (en) * 1998-03-11 1999-09-16 Smithkline Beecham Plc Composition
DE19918325A1 (de) * 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
FR2796840B1 (fr) * 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques Comprimes faiblement doses et procede de preparation
US6733781B2 (en) * 2000-12-06 2004-05-11 Wyeth Fast dissolving tablet
US8679533B2 (en) 2002-07-25 2014-03-25 Pharmacia Corporation Pramipexole once-daily dosage form
CN100563648C (zh) * 2003-04-25 2009-12-02 田边三菱制药株式会社 包含亚烷基二氧苯衍生物的口服组合物
WO2004100932A1 (en) * 2003-05-14 2004-11-25 Eurand Pharmaceuticals Ltd. Controlled drug release composition resistant to in vivo mechanic stress
US20050142191A1 (en) * 2003-06-23 2005-06-30 Neurochem (International) Limited Pharmaceutical formulations of amyloid inhibiting compounds
JP2005272347A (ja) * 2004-03-24 2005-10-06 Ohara Yakuhin Kogyo Kk 固形製剤の製造方法
KR101052436B1 (ko) 2004-08-13 2011-07-29 베링거 인겔하임 인터내셔날 게엠베하 프라미펙솔 또는 약제학적으로 허용되는 이의 염을함유하는 연장 방출형 정제 제형, 이의 제조방법 및 이의용도
KR20070050081A (ko) 2004-08-13 2007-05-14 베링거 인겔하임 인터내셔날 게엠베하 프라미펙솔 또는 약제학적으로 허용되는 이의 염을포함하는 연장 방출형 펠렛 제형, 이의 제조방법 및 이의용도
EP1970056A1 (en) * 2007-03-15 2008-09-17 Polichem S.A. Time-specific delayed/pulsatile release dosage forms
US9132096B1 (en) 2014-09-12 2015-09-15 Alkermes Pharma Ireland Limited Abuse resistant pharmaceutical compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2219636T3 (es) * 1989-04-13 2004-12-01 Beecham Group P.L.C. Nuevos compuestos.
GB9409718D0 (en) * 1994-05-14 1994-07-06 Smithkline Beecham Plc Novel compounds
GB9421472D0 (en) * 1994-10-25 1994-12-07 Smithkline Beecham Plc Novel methods
AR004178A1 (es) * 1995-07-29 1998-11-04 Smithkline Beecham Plc Procedimiento para la formulacion de un farmaco, una composicion farmaceutica obtenible mediante este procedimiento y el uso de la misma.

Also Published As

Publication number Publication date
JP2001500150A (ja) 2001-01-09
CN1446535A (zh) 2003-10-08
AU724086B2 (en) 2000-09-14
CO5031291A1 (es) 2001-04-27
NZ334268A (en) 2000-10-27
CN1235544A (zh) 1999-11-17
KR20000036039A (ko) 2000-06-26
MA24359A1 (fr) 1998-07-01
HUP9904401A2 (hu) 2000-06-28
IL128781A0 (en) 2000-01-31
ZA978133B (en) 1999-04-12
EP0929301A2 (en) 1999-07-21
WO1998010762A2 (en) 1998-03-19
NO991194L (no) 1999-03-11
AR008176A1 (es) 1999-12-09
CA2265661A1 (en) 1998-03-19
PL332074A1 (en) 1999-08-30
PE2499A1 (es) 1999-03-24
AU4128897A (en) 1998-04-02
CZ83299A3 (cs) 1999-08-11
NO991194D0 (no) 1999-03-11
HUP9904401A3 (en) 2001-03-28
GB9619074D0 (en) 1996-10-23
TR199900505T2 (id) 1999-06-21
BR9711734A (pt) 1999-08-24
WO1998010762A3 (en) 1998-06-04

Similar Documents

Publication Publication Date Title
DE69718508D1 (de) Antitraspirant zusammensetzung
NO985460D0 (no) Limsammensetning
DE69526966D1 (de) Hautkräftigende kometische zusammensetzung
DE69721231D1 (de) Anisotrop leitende zusammensetzung
IS5430A (is) Ný samsetning
ID16251A (id) Komposisi-komposisi pembasmi kuman
ID25508A (id) Komposisi dematologis
ID18359A (id) Komposisi mikrokapsul
FI954773A (fi) Antihypertriglyserideeminen koostumus
DE69733072D1 (de) Farbschonende zusammensetzungen
DE69719442D1 (de) Frisierschaum-Zusammensetzungen
ID23250A (id) Komposisi paroksetin
ID17561A (id) Komposisi untuk pemakaian luar
ID21906A (id) Komposisi adesif
ID19589A (id) Komposisi
DE59712835D1 (de) Stabilisierte monomerenzusammensetzung
ITMI940362A0 (it) Composizione antitosse
BR9509899A (pt) Composição modificadora de sabor
BR9707835A (pt) Composiç
DK0923562T3 (da) Substituerede p-trifluormethylphenyluraciler
BR9709815A (pt) Composicão
DE59707428D1 (de) Substituierte 1-methyl-3-benzyluracile
FI19992526A (fi) Sahakokoonpano
DE59711889D1 (de) Substituierte pyrazol-3-ylbenzazole
DE59708674D1 (de) Substituierte 3-phenylpyrazole